Press release

Notification of Full Year Results Date

20 February 2019

e-therapeutics plc (AIM: ETX, “e-therapeutics”), the network-driven drug discovery (NDD) company, will announce its full year results for the year ended 31st January 2019 on Tuesday, 5th March 2019.

Tags
Share
Sign up for press releases

Discover

Whats New?

Explore more

Tangram Therapeutics Announces Appointment of Laura Roca-Alonso, Ph.D. as Interim Chief Executive Officer

Mar 30, 2026

Tangram Therapeutics Announces First Participant Dosed in Phase 1/2 RESTORE-MASH Trial of TGM-312, a Novel Investigational RNAi Medicine

Mar 5, 2026

Tangram Therapeutics Submits Clinical Trial Application for Phase 1/2 Study of TGM-312, a Novel Investigational RNAi MASH Candidate

Nov 26, 2025

Tangram Therapeutics to Participate in Upcoming Investor and Scientific Conferences

Oct 3, 2025

e-therapeutics Relaunches as Tangram Therapeutics and Unveils LLibra OS

Oct 1, 2025

e-therapeutics De-risks Clinical Path for GalOmic Candidate ETX-312 with Positive Non-clinical Data

Jul 10, 2025

/